Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Tags » Phase Ii

Related tags: biotechnology, cancer, clinical trials, fda, healthcare, hepatitis, market news first, mn1, phase iii, research and development

  1. GTx shares surge on positive cancer drug data

    fiercebiotech.com » Untitled News Source - Oct 13, 2008

    Memphis-based GTx reported data from a successful mid-stage trial of its experimental therapy to improve body mass and muscle function in cancer patients. The data demonstrated that patients taking Ostarine performed

    Also tagged: gtx, clinical trial results, ostarine

  2. Services grievances against pay report no breach of discipline: IAF chief

    thaindian.com » Thaindian News - Oct 3, 2008

    By Praful Kumar Singh New Delhi, Oct 3 (ANI): The Chief of Air Staff, Air Chief Marshal Fali H Major, on Friday said the Armed Forces have not breached any discipline by publicly airing their grievances over the

    Also tagged: national, chiefs, breach, new delhi, anomalies, stagnation, avenues, grievances, praful, air chief marshal, anniversary celebrations, committee report, upgradation, sixth central pay commission, batches, air staff, h major, service commissions, age profile, fali

  3. Cabinet approves upgradation of 1,896 posts in armed forces

    thaindian.com » Thaindian News - Oct 3, 2008

    New Delhi, Oct 1 (ANI): The Union Cabinet today approved the Ministry of Defence’’s proposal for effecting the upgradation of 1,896 posts in the services. The move is a major step to improve career mobility, to fulfill

    Also tagged: national, new delhi, consensus, ajay, antony, union cabinet, battalion, defence ministry, stagnation, ministry of defence, aspirations, defence minister, personal interest, lieutenant colonel, batches, age profile, brigade level, career mobility, combat effectiveness, commanding officers

  4. Cytokinetics touts data from heart failure trial

    fiercebiotech.com » Untitled News Source - Sep 24, 2008

    A small mid-stage study has produced positive interim data for Cytokinetics' experimental drug CK-1827452. A full set of data will be delivered to Amgen--which has an option to co-develop the drug--by the end of the

    Also tagged: amgen, cytokinetics, clinical trial results, ck 1827452

  5. Regeneron's Arcalyst a success in mid-stage trial

    fiercebiotech.com » Untitled News Source - Sep 3, 2008

    Regeneron Pharmaceuticals is reporting a success in the mid-stage trial of its gout drug Arcalyst. Researchers say the drug reduced gout flares by 81 percent in the 83-person study. And it hit its main goal by beating

    Also tagged: regeneron, arcalyst

  6. Pipex acquires mid-stage RA program

    fiercebiotech.com » Untitled News Source - Aug 19, 2008

    Pipex Pharmaceuticals has acquired oral dnaJP1, a once-daily candidate for the treatment of rheumatoid arthritis which has completed a 160 patient Phase II clinical trial for the treatment of rheumatoid arthritis

    Also tagged: rheumatoid arthritis, pipex, clinical trial news, nicholas stergis

  7. Recreaciones del restyling del Renault Clio III y del Espace IV

    motorspain.com » Motor Spain - Aug 13, 2008

    Aunque los últimos rumores señalaban que el Espace podría dejar de existir dadas sus bajas ventas y la época de crisis en la que nos encontramos, lo cierto es que confirmación oficial a ese respecto no existe. Muchos

    Also tagged: facelift, clio, espace, compactos, restyling, monovolumen, renault dacia, recreaciones, fase 2

  8. Merck suspends trial enrollment

    fiercebiotech.com » Untitled News Source - Aug 11, 2008

    SurModics says that Merck informed the company that results reported in a recently published study comparing laser treatment and intravitreal injections of triamcinolone acetonide in patients with diabetic macular

    Also tagged: merck, surmodics

  9. Lilly pays $35M to land TransPharma pact

    fiercebiotech.com » Untitled News Source - Jun 12, 2008

    Eli Lilly is forking over a $35 million upfront payment to nail down the worldwide licensing rights to TransPharma Medical's ViaDerm-hPTH osteoporosis product and a non-exclusive license to its Read more...

    Also tagged: deals, osteoporosis, milestones, eli lilly, evista, mergers and acqusitions, transpharma, biotech drugs, gwen krivi

  10. Jazz Pharma axes staffers after delaying two trials

    fiercebiotech.com » Untitled News Source - Jun 12, 2008

    Jazz Pharmaceuticals says it needs to extend the development time line for two key drug programs, a move that triggered a decision to lay off 33 workers, or eight percent of its workforce. In a Read more...

    Also tagged: workforce, pharmaceuticals, layoffs, ipo, bipolar, phase iii, jazz pharmaceuticals, samuel saks, jzp 7, jzp 4

1  2  3